European Commission Clinical Trials
Sponsors / European Commission
149 ClinicalTrials.gov entries name European Commission as the lead sponsor. The portfolio currently includes 11 recruiting studies, 1 active non-recruiting studies, and 96 completed studies. 10 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Cumulative planned enrollment across all listed trials is 2,715,970 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
149
Total Trials
11
Recruiting
1
Other Active
96
Completed
10
Terminated / Withdrawn
2,715,970
Total Enrollment
Termination reasons: Recruitment40% · Other40% · Safety10% · Funding10%
Recent Terminations
- NCT04456400 Stopped Apr 2025Crohn Disease"The termination is based on a shifted commercial interest of the Sponsor and is not related to any safety grounds."
- Diabetic Foot Ulcer"Patient recruitment issues"
- Venous Leg Ulcer"The continuation of the study was rendered unreasonable due to the slow inclusion rate"
- Out-Of-Hospital Cardiac Arrest"low rate recruitment"
- NCT03016260 Stopped Dec 2019RheumatoId Arthritis
- Intensive Care Unit Syndrome"insufficient inclusions"
- Chronic Pain"The study was early terminated due to insufficient recruitment"
- Epithelial Ovarian Cancer"production of IMP has stopped"
- Osteosarcoma"Failed to recruit sufficient numbers of patients in the funded period"
- Contrast Media"Lack of funding"
Active Trials (1 total)
- NCT05701228
- NCT06816147
- Brain Tumor NANCT06368310
- NCT05223413
- NCT06179602
- NCT05994690
- NCT03571373
- NCT05554835
- Healthy NANCT06567054
- NCT06436937
- Cancer NANCT06007001
- NCT04952870